With mon­ey flow­ing, Pli­ant Ther­a­peu­tics heads to pub­lic well

Fresh off rais­ing a $100 mil­lion Se­ries C and send­ing their sec­ond com­pound in­to the clin­ic, Pli­ant Ther­a­peu­tics is head­ed for Wall Street. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.